Visa's $2.4 Billion BioCatch Deal Puts Israeli Fintech on the Global Map

Visa's decision to acquire Tel Aviv-based BioCatch for $2.4 billion in cash ranks among the largest exits in Israeli tech history and a defining moment for the country's fintech and cyber sectors. The deal, announced this week, brings a decade-old behavioral biometrics pioneer under the umbrella of the world's largest payments network, with the transaction expected to close by mid-2027. For Israeli startups, it signals renewed global appetite for homegrown security technology at premium valuations.

Visa's $2.4 Billion BioCatch Deal Puts Israeli Fintech on the Global Map

Tel Aviv, Israel — Visa and BioCatch confirmed on Monday that the two companies have signed a definitive agreement under which Visa will acquire the Tel Aviv-based anti-fraud firm for $2.4 billion in cash from funds advised by Permira and other shareholders. The transaction remains subject to customary closing conditions, including regulatory approvals.

The Announcement and Deal Structure

Visa announced this week that it signed a definitive agreement to acquire Tel Aviv-based BioCatch for $2.4 billion in cash. The transaction involves funds advised by Permira along with other shareholders. The deal was announced on Monday and remains subject to customary closing conditions including regulatory approvals. It is expected to close by mid-2027.

BioCatch Background and Growth Trajectory

BioCatch was founded in 2011 in Tel Aviv by the late Avi Turgeman and Benny Rosenbaum. The company pioneered behavioral biometrics for fraud detection. Under CEO Gadi Mazor, who joined in 2018 when annual revenue stood near $7 million and valuation around $100 million, the firm expanded rapidly. Annual recurring revenue crossed $100 million by 2023 following 49 percent growth that year and achieved 43 percent ARR growth in 2025 while reaching EBITDA profitability.

Today BioCatch employs 400 people and protects 1.8 billion devices along with 760 million users worldwide. It serves more than 350 banking clients across 21 countries, including over 100 of the largest banks globally. Early investors included Jerusalem-based OurCrowd along with Maverick Ventures, Joule Ventures, Bloomberg Capital, Elroy Capital and Kraus controlled by BlackRock.

Permira's Role and Valuation History

Permira acquired a controlling stake in BioCatch approximately two years ago at a valuation near $1.3 billion, investing about $750 million for roughly 60 percent ownership. The transaction was led by Ran Maidan, Permira's Israeli partner, with Bain Capital and Maverick Ventures selling shares worth $750 million at that time. The current $2.4 billion price represents an increase of more than $1 billion in roughly 15 months, marking one of the largest exits in the Israeli tech sector.

The rapid appreciation in value over a short holding period underscores how private equity has increasingly viewed Israeli fintech as a high-conviction asset class capable of delivering outsized returns even in volatile macro environments. This trajectory reflects broader industry dynamics where behavioral analytics platforms have moved from niche defensive tools to core infrastructure for global financial institutions seeking differentiation in crowded payments markets.

Core Technology and Product Offerings

BioCatch uses AI and machine-learning platforms to analyze thousands of application, behavioral, device and network signals in real time. These include keystroke timing, touch gestures, touchscreen pressure, device handling, mouse movements and browsing habits. The system distinguishes legitimate users from fraudsters and bots during digital sessions.

Product suites include BioCatch Connect, Align SDK, Fuse, DeviceIQ and Scams360. These tools address account takeover protection, romance and investment scams, money mules, money laundering networks, application fraud, bot attacks, malware and RAT attacks, SIM swapping, OTP social engineering and account opening fraud.

Scale of Global Fraud Challenges

Account takeovers and scams cost the global economy more than $1 trillion annually. Visa estimates that generative AI is enabling attacks at unprecedented scale by making them cheaper, faster and more convincing. BioCatch's behavioral-first approach provides real-time intelligence that can identify threats before they reach payment rails.

Generative AI has lowered the barrier for sophisticated social engineering by enabling real-time adaptation of phishing scripts and voice cloning that bypass traditional verification layers. Account takeover attempts now frequently combine stolen credentials with synthetic media that mimics user behavior closely enough to evade static checks, forcing institutions to layer continuous authentication throughout sessions rather than at login alone. This evolution has elevated behavioral biometrics from a supplementary signal to a primary differentiator, as metrics like keystroke rhythm and device interaction pressure prove harder to replicate than passwords or one-time codes.

Visa Executive Perspective

Andrew Torre, president of value-added services at Visa, stated that account takeovers and scams cost the global economy over $1 trillion annually and that AI is enabling these attacks at unprecedented scale. He noted that BioCatch will help clients stop fraud before it reaches the point of payment. The acquisition aligns with Visa's strategy to help clients prevent cyber threats upstream and build trust into every transaction.

Visa processes more than 329 billion transactions annually worth over $17 trillion and connects approximately 14,500 financial institutions. The company has invested more than $13 billion in technology and infrastructure over the last five years to safeguard the payments ecosystem. Its value-added services division, which includes fraud prevention, cybersecurity and analytics software, ranks among the fastest-growing parts of the business.

BioCatch Leadership Outlook

Gadi Mazor, BioCatch CEO and former OurCrowd partner, emphasized that real-time insights into customer intent are increasingly essential for institutions to establish trust within digital banking sessions. He highlighted the company's decade-long demonstration of behavior's ability to distinguish criminals from legitimate users and the recent success of real-time intelligence-sharing networks among customers.

Mazor informed employees that BioCatch will continue operating as a standalone business within Visa. Leadership team, reporting structure and customer relationships will remain unchanged. He confirmed he is not leaving and stated the company is not going away but will operate as part of Visa while advancing its mission of making the world a safer place to transact.

Israeli Tech Ecosystem Context

This transaction represents one of the biggest-ever deals in the Israeli tech sector and the second sale of BioCatch, this time involving all company shares. Behavioral biometrics has emerged as a distinct Israeli innovation cluster with companies such as BioCatch, Callsign, Au10tix and IdentityMind active in the space. The exit underscores how payments companies are racing to strengthen fraud defenses amid generative AI threats.

Tel Aviv and Herzliya have coalesced into a dense cluster where cybersecurity and fintech expertise intersect daily through shared talent pools, military alumni networks and specialized accelerators. Local vehicles such as OurCrowd have played a catalytic role by providing not only capital but also structured access to global limited partners, enabling companies to secure follow-on rounds from overseas without relocating headquarters.

The pattern of exits to global payments and technology leaders reinforces Israel's position as an origination hub whose firms are integrated into larger platforms rather than scaled independently to IPO. Such transactions inject liquidity back into the ecosystem, funding new ventures and retaining engineering talent that might otherwise migrate.

Implications for Regional Innovation and Daily Life

Israeli startups in Herzliya, Beersheba and Tel Aviv continue to develop solutions that address worldwide financial crime challenges. BioCatch's technology already safeguards users across multiple continents while drawing on talent and infrastructure concentrated in Israel's tech hubs. The acquisition reinforces the country's position as a source of specialized tools that integrate into global payment networks, supporting both local employment and global transaction security.

Looking Ahead for the Sector

The combination positions BioCatch's behavioral intelligence within Visa's extensive client base while preserving operational independence. Visa's acquisition strengthens its position in the payments security stack relative to competing networks that have historically emphasized processing scale over behavioral intelligence, potentially prompting rivals to accelerate their own capability builds or partnerships.

Maintaining BioCatch as a distinct operating unit could allow continued focus on core detection algorithms while expanding into adjacent use cases such as real-time agentic AI threat modeling, where autonomous systems increasingly interact with financial interfaces. For Israeli founders and engineers, the deal demonstrates that deep-domain expertise developed locally can achieve global distribution through strategic channels without requiring full-scale commercialization infrastructure.

By Hannah Berg, Staff Writer

This article was produced with AI-assisted research and editorial support. Reporting is based on sources cited in the article.